tiprankstipranks
Aurinia Pharmaceuticals (GB:0UJF)
LSE:0UJF
Holding GB:0UJF?
Track your performance easily

Aurinia Pharmaceuticals (0UJF) Income Statement

0 Followers

Aurinia Pharmaceuticals Income Statement

Last quarter (Q3 2024), Aurinia Pharmaceuticals's total revenue was $67.77M, an increase of 24.32% from the same quarter last year. In Q3, Aurinia Pharmaceuticals's net income was $14.35M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 220.36M$ 175.51M$ 134.03M$ 45.60M$ 50.12M$ 318.00K
Cost of Revenue
$ 28.09M$ 14.15M$ 5.66M$ 1.09M-$ 52.87M
Gross Profit
$ 192.27M$ 161.37M$ 128.37M$ 44.51M$ 50.12M$ -52.55M
Operating Expense
$ 223.82M$ 253.06M$ 241.36M$ 225.25M$ 154.41M$ 76.34M
Operating Income
$ -32.53M$ -91.69M$ -112.99M$ -180.74M$ -104.29M$ -76.02M
Net Non Operating Interest Income Expense
$ 12.55M$ 14.22M$ 5.12M$ -529.00K$ -1.52M$ -2.70M
Other Income Expense
$ 10.16M$ 8.38M$ 1.52M-$ -6.81M$ -14.92M
Pretax Income
$ -20.78M$ -77.47M$ -109.40M$ -180.21M$ -102.77M$ -88.24M
Tax Provision
$ 2.41M$ 551.00K$ 1.83M$ 760.00K$ -94.00K$ 144.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -22.55M$ -78.02M$ -111.23M$ -180.97M$ -102.68M$ -88.39M
Basic EPS
$ -0.15$ -0.54$ -0.76-$ -0.87$ -1.33
Diluted EPS
$ -0.15$ -0.54$ -0.76-$ -0.87$ -1.33
Basic Average Shares
$ 575.07M$ 143.24M$ 141.91M-$ 118.47M$ 93.02M
Diluted Average Shares
$ 578.45M$ 143.24M$ 141.91M-$ 118.47M$ 93.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 251.91M$ 267.20M$ 247.02M$ -226.34M$ -154.41M$ -76.34M
Net Income From Continuing And Discontinued Operation
$ -22.55M$ -78.02M$ -111.23M$ -180.97M$ -102.68M$ -88.39M
Normalized Income
$ -5.92M$ -56.94M$ -80.41M$ -132.45M$ -102.87M$ -63.67M
Interest Expense
------
EBIT
$ -15.14M$ -74.69M$ -109.40M$ -180.21M$ -102.77M$ -88.20M
EBITDA
$ -8.67M$ -75.19M$ -93.57M$ -177.44M$ -101.40M$ -87.03M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis